195 related articles for article (PubMed ID: 28423595)
1. dUTPase inhibition augments replication defects of 5-Fluorouracil.
Hagenkort A; Paulin CBJ; Desroses M; Sarno A; Wiita E; Mortusewicz O; Koolmeister T; Loseva O; Jemth AS; Almlöf I; Homan E; Lundbäck T; Gustavsson AL; Scobie M; Helleday T
Oncotarget; 2017 Apr; 8(14):23713-23726. PubMed ID: 28423595
[TBL] [Abstract][Full Text] [Related]
2. dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.
Yokogawa T; Yano W; Tsukioka S; Osada A; Wakasa T; Ueno H; Hoshino T; Yamamura K; Fujioka A; Fukuoka M; Ohkubo S; Matsuo K
Cancer Sci; 2021 Jan; 112(1):422-432. PubMed ID: 33140501
[TBL] [Abstract][Full Text] [Related]
3. dUTP nucleotidohydrolase isoform expression in normal and neoplastic tissues: association with survival and response to 5-fluorouracil in colorectal cancer.
Ladner RD; Lynch FJ; Groshen S; Xiong YP; Sherrod A; Caradonna SJ; Stoehlmacher J; Lenz HJ
Cancer Res; 2000 Jul; 60(13):3493-503. PubMed ID: 10910061
[TBL] [Abstract][Full Text] [Related]
4. Novel opportunities for thymidylate metabolism as a therapeutic target.
Wilson PM; Fazzone W; LaBonte MJ; Deng J; Neamati N; Ladner RD
Mol Cancer Ther; 2008 Sep; 7(9):3029-37. PubMed ID: 18790783
[TBL] [Abstract][Full Text] [Related]
5. Small interfering RNA-mediated suppression of dUTPase sensitizes cancer cell lines to thymidylate synthase inhibition.
Koehler SE; Ladner RD
Mol Pharmacol; 2004 Sep; 66(3):620-6. PubMed ID: 15322254
[TBL] [Abstract][Full Text] [Related]
6. Structure/function analysis of a dUTPase: catalytic mechanism of a potential chemotherapeutic target.
Harris JM; McIntosh EM; Muscat GE
J Mol Biol; 1999 Apr; 288(2):275-87. PubMed ID: 10329142
[TBL] [Abstract][Full Text] [Related]
7. Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5-fluorouracil chemotherapy.
Martino-Echarri E; Henderson BR; Brocardo MG
Oncotarget; 2014 Oct; 5(20):9889-900. PubMed ID: 25301724
[TBL] [Abstract][Full Text] [Related]
8. The role of dUTPase and uracil-DNA repair in cancer chemotherapy.
Ladner RD
Curr Protein Pept Sci; 2001 Dec; 2(4):361-70. PubMed ID: 12374095
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Dr-dut gene causes DNA damage in planarian.
Alam MS; Moriyama H; Matsumoto M
Mol Reprod Dev; 2018 Mar; 85(3):188-196. PubMed ID: 29405473
[TBL] [Abstract][Full Text] [Related]
10. The 1,2-Diaminocyclohexane Carrier Ligand in Oxaliplatin Induces p53-Dependent Transcriptional Repression of Factors Involved in Thymidylate Biosynthesis.
Kiyonari S; Iimori M; Matsuoka K; Watanabe S; Morikawa-Ichinose T; Miura D; Niimi S; Saeki H; Tokunaga E; Oki E; Morita M; Kadomatsu K; Maehara Y; Kitao H
Mol Cancer Ther; 2015 Oct; 14(10):2332-42. PubMed ID: 26208523
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of combined administration with CPT-11 and 5-fluorouracil in vitro and in vivo.
Satoh H; Ohtomo M; Ishikawa H; Kamma H; Ohtsuka M; Hasegawa S
Cancer Biochem Biophys; 1999 Jul; 17(1-2):59-67. PubMed ID: 10738902
[TBL] [Abstract][Full Text] [Related]
12. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
Hsueh CT; Kelsen D; Schwartz GK
Clin Cancer Res; 1998 Sep; 4(9):2201-6. PubMed ID: 9748140
[TBL] [Abstract][Full Text] [Related]
13. Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage.
Wilson PM; Fazzone W; LaBonte MJ; Lenz HJ; Ladner RD
Nucleic Acids Res; 2009 Jan; 37(1):78-95. PubMed ID: 19015155
[TBL] [Abstract][Full Text] [Related]
14. A novel mechanism of checkpoint abrogation conferred by Chk1 downregulation.
Xiao Z; Xue J; Sowin TJ; Rosenberg SH; Zhang H
Oncogene; 2005 Feb; 24(8):1403-11. PubMed ID: 15608676
[TBL] [Abstract][Full Text] [Related]
15. [Potentiation of 5-fluorouracil efficacy. Molecular mechanisms playing a role in the cytotoxic action of 5-fluorouracil and 5-ethyl-2'-deoxyuridine (EUdR) combination].
Katona C; Timár F; Oláh J; Bocsi J; Budai B; Otvös L; Kralovánszky J
Magy Onkol; 2004; 48(3):243-51. PubMed ID: 15520875
[TBL] [Abstract][Full Text] [Related]
16. TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-Based Chemotherapy.
Yano W; Yokogawa T; Wakasa T; Yamamura K; Fujioka A; Yoshisue K; Matsushima E; Miyahara S; Miyakoshi H; Taguchi J; Chong KT; Takao Y; Fukuoka M; Matsuo K
Mol Cancer Ther; 2018 Aug; 17(8):1683-1693. PubMed ID: 29748212
[TBL] [Abstract][Full Text] [Related]
17. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
18. dUTPase and uracil-DNA glycosylase are central modulators of antifolate toxicity in Saccharomyces cerevisiae.
Tinkelenberg BA; Hansbury MJ; Ladner RD
Cancer Res; 2002 Sep; 62(17):4909-15. PubMed ID: 12208740
[TBL] [Abstract][Full Text] [Related]
19. A potential important role for thymidylate synthetase inhibition on antitumor activity of fluoropyrimidine and raltitexed.
Kabeshima Y; Kubota T; Watanabe M; Saikawa Y; Nishibori H; Hasegawa H; Kitajima M
Anticancer Res; 2002; 22(6A):3245-52. PubMed ID: 12530071
[TBL] [Abstract][Full Text] [Related]
20. Discovery of highly potent human deoxyuridine triphosphatase inhibitors based on the conformation restriction strategy.
Miyahara S; Miyakoshi H; Yokogawa T; Chong KT; Taguchi J; Muto T; Endoh K; Yano W; Wakasa T; Ueno H; Takao Y; Fujioka A; Hashimoto A; Itou K; Yamamura K; Nomura M; Nagasawa H; Shuto S; Fukuoka M
J Med Chem; 2012 Jun; 55(11):5483-96. PubMed ID: 22607122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
